Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
Ontology highlight
ABSTRACT: BACKGROUND:More alternatives have become available for the diagnosis and treatment of cancer in low- and middle-income countries. Because of increasing demands, governments are now facing a problem of limited affordability and availability of essential cancer medicines. Yet, precise information about the access to these medicines is limited, and the methodology is not very well developed. We assessed the availability and affordability of essential cancer medicines in Mexico, and compared their prices against those in other countries of the region. METHODS:We surveyed 21 public hospitals and 19 private pharmacies in 8 states of Mexico. Data were collected on the availability and prices of 49 essential cancer medicines. Prices were compared against those in Chile, Peru, Brazil, Colombia and
SUBMITTER: Moye-Holz D
PROVIDER: S-EPMC7222474 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
ACCESS DATA